Decisions of the High Court of Australia:

• Kimberly-Clark v Arico (sufficiency of patents, nappies)
• Grain Pool of Western Australia v The Commonwealth (constitutional validity of Plant Varieties Act)
• Astra v Alphapharm (inventive step, omeprazole formulation)
• Alphapharm v Lundbeck (power to grant extensions of time for filing an extension of term, appeal dismissed)
• D’Arcy v Myriad (patentability of breast cancer genes, application to intervene by the Institute of Patent and Trade Mark Attorneys)

Special Leave Applications to High Court of Australia:

• UWA v Gray (entitlement)
• Samsung v Apple (interlocutory injunction)
• Alphapharm v Lundbeck (extension of term)
• Nichia v Arrow (LED lights, inventive step)
• Globaltech v Australian Mud (method for drilling, construction and infringement)

Decisions of the Full Federal Court of Australia:

• Asahi v Grace (patent for shrink wrap plastic, trial and appeal)
• Tidy Tea v Unilever (patent for dripless teabags, trial and appeal)
• Genetics Institute v Amgen (patent for the hormone, erythropoietin, trial and appeal)
• Atlantis v Schindler (patent for drainage cells, appeal)
• 3M v Tyco (patent for electrical connectors, trial and appeal)
• Gambro v Fresenius (patent for dialysis machines, trial, appeal and trial as to damages)
• Eli Lilly v Pfizer (patent for use of Viagra to treat erectile dysfunction, trial and appeal)
• Conor v Angiotech (patent for taxol stents, hearing and appeal on entitlement; also a member of the team of barristers that argued the case in the House of Lords)
• Merck v Arrow (patent for the drug, alendronate; trial and appeal)
• Emperor Sports v Commissioner of Patents (for Commissioner in appeal regarding re-examination procedures)
• IGT v Aristocrat (games for poker machines, trial and appeal)
• Alphapharm v Lundbeck (patent for the anti-depressant drug, escitalopram, trial and appeal; appeal to AAT regarding extension of time and appeal to Full Court and further appeal to High Court; opposition to application for extension of term in Patents Office, appeal to Federal Court and further appeal to Full Federal Court and High Court; further infringement proceedings)
• DuPont v ICI and the Commissioner of Patents (for Commissioner in appeal regarding opposition procedures)
• Novozymes v Danisco (patent relating to an enzyme (lipase) used in baking bread, trial and appeal)
• Apotex v Eli Lilly (patent for olanzapine, used to treat schizophrenia, trial and appeal)
• Apotex v AstraZeneca (patents relating to rosuvastatin, a cholesterol-lowering agent, trial and appeal)
• Reckitt Benckiser v Glaxo SmithKline (syringes, interlocutory injunctions, appeals and trial)
• Nichia v Arrow (LEDs, trial and appeal)
• Meat and Livestock Authority v Cargill / Branhaven (method for genetic selection of cattle – appeal from opposition and amendment; appeal from amendment decision)
• Globaltech v Australian Mud (drilling, trial and appeal)
• Merck (MSD) v Wyeth (Pfizer) (patents relating to pneumococcal vaccines, trial and appeal – matter settled after May 2021 hearing of appeal before judgment)

Federal Court of Australia (cases resulting in at least one published decision):

• Alphapharm v Tanabe (patent for a beta-blocker, term extension trial)
• Murex v Chiron (patent for the hepatitis C virus, trial)
• Biochem v Emory (patent for the drug 3TC, used to treat AIDS, hearing and appeal)
• Genetics Institute v Johnson (prior claiming, appeal from patent office)
• New England Biolabs v Hoffman La-Roche (patent for the enzyme, taq polymerase, used in PCR, trial)
• Mycogen v Monsanto (patent for genetically engineered cotton plants, trial)
• Hexal v Hoffmann La Roche (patent for carvedilol to treat heart failure, interlocutory injunction)
• Merck v Genrx (patent for the drug, alendronate, used to treat osteoporosis, interlocutory injunction)
• Clark v Coffey (patent for a method for detecting opal deposits, trial)
• Pfizer v Commissioner of Patents (extension of patent for anti-fungal drug, voriconazole, trial and appeal)
• Sheiman v Novopharm (conspiracy claim relating to patent applications for sterilisation apparatus)
• Interpharma v Lilly (patent for gemcitabine, anti-cancer agent, interlocutory injunction)
• Inverness v MDS (pregnancy testing kits, trial)
• Hospira v Amgen (patent for PEG-GCSF, a pegylated hormone used to increase blood cell count)
• Samsung v Apple (smartphone technology, trial)
• Merck v Apotex (mometasone furoate nasal spray, interlocutory injunction)
• DSM v Suntory (arachidonic acid composition and process for production, appeal from opposition)
• Hoffmann-La Roche v Apotex (patent relating to valganciclovir, an anti-viral drug)
• Merck v Ono Pharmaceuticals (patent relating to anti-PD1 monoclonal antibodies, worked with barristers in UK trial in 2017, AU case settled before trial)
• Blueport Nominees v Sewerage Management Services (pipe connectors for use in sewerage, trial)
• Voxson v Optus, Telstra and Vodafone (patents relating to GPS technology and video streaming, various interlocutory hearings)
• Merial v Intervet (soft chew anti-parasitic formulation, appeal from opposition)
• Tytec v General Transport (trailers, appeal from opposition)
• Ansell v Reckitt Benckiser (synthetic latex condoms, various interlocutory hearings and trial end 2016 – matter settled before judgment)
• Hoffmann La-Roche v Sandoz (Mabthera – anti-cancer/arthritis antibody, interlocutory injunction)
• Vector v Duoguard (corrosion mitigation, trial)
• Hanwha v Jinko and Ors (solar cells, various interlocutory hearings)
• Perfect Day v Fonterra (biotech dairy substitutes, appeal from opposition, amendment application) (preparation for trial)
• CIPLA v Bayer (rivaroxaban, anti-blood clotting drug, revocation proceedings (withdrawn)
• EIS v LELO (sexual stimulation devices, infringement/revocation proceedings) (trial)
• Sun Pharma v Otsuka and Lundbeck (aripiprazole formulation patent, trial and appeal)
• Pfizer v Samsung Bioepsis, Merck and Organon (process for manufacturing etanercept, infringement, validity and amendment proceedings) (trial)

Australian Patent Office (oppositions):

• Genentech v Celltrix (insulin like growth factor binding protein)
• Tioxide v Kerr McGee (process for manufacturing titanium dioxide)
• CSIRO v Bio-Care (method for controlling termites)
• DSM NV v Novo Nordisk (patent for Aspergillus tubigensis XYL b enzyme)
• Affymax v Diversa (DNA shuffling)
• Human Genome Sciences v Ludwig (VEGF2 protein)
• SmithKline Beecham v Lek (combination of amoxicillin and clavulanate)
• Genentech v HGS (VEGF–related protein)
• Bluescope v IGS Technologies (coated steel compositions)
• Novogen v GJ Consultants (entitlement)
• Novozymes A/S v DSM N. V. (methods for expression cloning in filamentous fungi)
• Nestle v Effem (canned pet food)
• Oravax v CSL (Helicobacter vaccine)
• Bayer v Novartis (endoparasiticidal agents)
• Ashmont v Nature Vet (anthelmintic formulations)
• Orenco v Everhard (septic tanks)
• Merck v Sherman (enalapril formulation)
• Fexco DCC v Mainline (method for foreign currency conversion)
• Euro-celtique v Grunenthal; Grunenthal v Mundipharma (opioid formulations)
• Unilever v Nestec (ice confections)
• CSR v Renouf (laminated insulating material)
• Sheiman v Novapharm (sterilisation apparatus)
• Vistakon v Novartis (contact lenses)
• NewSouthInnovations v Kaczmarek (entitlement)
• Alphapharm & Ors v Lundbeck (anti-depressant – extension of time application, following opposition and subsequent appeals)
• Haas v Steiner (anti-microbial agents)
• Novartis v Bayer (endoparasiticidal agents)
• Martek v Suntory (process for manufacturing oils used in infant formula)
• Shell v Exxon (process for removing contaminants from gas)
• Exxon v Shell (gasoline formulation)
• Apotex v AstraZeneca (rosuvastatin formulation)
• QNL v Cominco (process for extraction of minerals from ores)
• Sandoz v Euroceltique (tramadol formulation)
• Unnamed opponent (Mr Carter) v Cristal Inc (titanium alloy)
• Unnamed opponent (Mr Cox) v Abbott Laboratories (infant milk formula)
• Northern Rivers v Cougar Biotech (Johnson & Johnson) (treatment for prostate cancer)
• Fonterra v Corman (milk product)
• Evonik v Sudzucker (sugar sweetener)
• Intervet v DuPont (anti-parasitic formulations)
• Cargill v Dow Agroscience (genetically modified canola plants, seeds and oils)
• TasAlks v TPI and Sun (high codeine poppies)
• Regeneron v Kymab (transgenic mice, submissions only)
• Sigma-Aldrich v JH Corporate Services (CRISPR gene-editing techniques)
• Astellas Pharma v Aragon Pharmaceuticals (treatment for prostate cancer)
• Rozenberg v Fred Hutchinson Cancer Research Centre / Seattle Children’s Hospital (CAR T-cell therapies to treat cancer)
• QIP Nominees v Dana Farber Institute (personalized cancer vaccines using mutated peptides)

Bachelor of Science with Honours (pharmacology) (First Class), Monash University (Melbourne)

Bachelor of Law with Honours (Class IIa), Melbourne University